Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2023

Medicamentos do CPA 2021/44

Contract value
€16,314.13
Signed on
17 January 2023
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9937433

PUBLISHED SUBJECT

41 374/2023 - Medicamentos do CPA 2021/44

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
ANGELINI FARMACÊUTICA, LDA. · Tax ID 500583650
Awardee
GENERIS - FARMACEUTICA, S.A. · Tax ID 508107997
Awardee
Hikma Farmacêutica (Portugal) SA. · Tax ID 502266791
Awardee
KORANGI - PRODUTOS FARMACEUTICOS · Tax ID 505322307
Awardee
LABESFAL-LAB. ALMIRO, SA. · Tax ID 501169580

HOW MUCH AND WHEN

Values and timeline

Contract price
€16,314.13
Procedure base price
€16,314.13
Total effective price
Not reported on Portal BASE
Publication date
19 April 2023
Award date
17 January 2023
Signing date
17 January 2023
Performance period
366 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2021/44 - Medicamentos analgésicos, antipiréticos e antidepressivos
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
6452581

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts